Abstract

Background: Coronary heart disease is one of the leading cause of mortality in the world. D-dimer is direct marker of on going coagulation with fibrinolysis and high sensitive-C reactive protein not only marker of low grade chronic systemic inflammation but also directly involved in atherosclerosis. Objectives: The aim of present was to investigate the diagnostic potential of the plasma D-Dimer and high sensitive-C reactive protein as inflammatory markers in Coronary heart disease. Methods: In present case-control study 265 with various types coronary heart disease (age range 26 to 75) and 120 healthy age and sex matched volunteers formed the control group. Nyco Card reader was used for plasma D-Dimer estimation whereas high sensitive C-reactive protein was estimated by Latex turbidimetric method. Statistical software SYSTAT version-12 was used to analyze the data. Values were expressed as mean ± standard deviation and Comparisons of study groups and study groups to control groups were done by applying Z test. one way analysis of variance (ANOVA) test and tukey-Kramer multiple comparison test were used comparison. Results: Plasma D-Dimer and high sensitive C-reactive protein levels were significantly higher (p<0.01) in patients with Coronary heart disease like Stable Angina, Unstable Angina and Myocardial Infacrction as compared to healthy controls. Conclusion: D-Dimer seems to be independent cardiovascular risk factors, which might add relevant information. Circulating level of hs-CRP was significantly increased in patients with all types of Coronary heart disease but patients with Stable Angina had low level of high sensitive-C reactive protein as compared with patients with Unstable Angina and Myocardial infarction which shows that its role as acute inflammatory marker.

• 1.   Harsh Mohan. Textbook of pathology forward Ivan Danjanov. 5th ed. Anshan publishers; 1st April 2005. P. 305-326.
• 2.   C-reactive protein, inflammation and coronary heart disease. Amit Kumar Shrivastava, Harsh Vardhan Singh, Arun Raizada, Sanjeev Kumar Singh. The Egyptian Heart Journal 2015; 67: 89-97.
• 3.   Raja Babu Panwar, Rajeev Gupta, Bal Kishan Gupta, Sadiq Raja, Jaishree Vaishnav, Meena khi Khatri, et al. Atherothrombotic risk factors and premature coronary heart disease in India: A case – control study. Indian J Med Res. 2011; 134: 26-32.
• 4.   Orak M, Ustundag M, Guloglu C, Alyan O, Sayhan MB. The role of serum D - Dimer level in the diagnosis of patients admitted to the emergency department complaining of chest pain. The Journal of International Medicine Research. 2010; 38:1772 1779.
• 5.   Gordon DO Lowe, Ann Rumley, Peter M Sweetnam, John WG Yarnell, Joseph Rumley. Fibrin D-Dimer, markers of coagulation activation and the risk of major ischemic heart disease in the caerphilly study. Thromb Haemost. 2001; 85: 822-7.
• 6.   Danesh J, Whincup P, Walker M, et al. Fibrin D- Dimer and coronary heart disease: prospective study and meta-analysis. Circulation. 2001; 103:2323-2327.
• 7.   Kojuri J, Karimi A, Pourafshar N, Vosoughi AR. Association between serum levels of Hs-CRP and LDL - C with degree of coronary artery stenosis in patients with stable angina pectoris. Iranian Red Cresent Medical Journal. 2010; 12(4):396-405.
• 8.   Hisatomi Arima, Michiaki Kubo, Koji Yonemoto, Yasufumi Doi, Toshiharu Ninomiya, Yumihiro Tanizaki, et al. High sensitive C-reactive protein and coronary heart disease in general population of Japanese; the hisayama study. Arterioscler Thromb Vasc Biol. 2008; 28:1385-1391.
• 9.   Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003; 107: 363-369.
• 10.   Sudha Thakur, Shallu Gupta, Hundal Parchwani, Vidhi Shah, Vandana Yadav. Hs-CRP – potential markers for coronary heart disease. Indian Journal of Fundamental and Applied Life Sciences. 2011; 1:1-4.
• 11.   Dale S et.al. Comparison of three D - Dimer assays for the diagnosis of DVT: ELISA, Latex and immunofiltration Assay. (Nycocard D-Dimer). Thromb Heamostasis.1994; 71:270-274.
• 12.   Ridker PM, Hennekens CH, Buring JE, Refai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. The New England of Medicine. Mar 2000; 23:836-843.
• 13.   Collinson P, Gaze D, Bainbridge K. Utility of admission cardiac Troponin and Ischemia modified albumin measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department. Emerg Med J. 2006; 23:256-261.
• 14.   Najafi M, Gohari L, Firoozrai M, Zavarehee A, Basiri HA. Association between paraoxonase-1 gene promoter T (-107) C polymorphism and coronary artery disease. Iranian J Publ Health. 2008; 37(1):108-113.
• 15.   Kruskal JB, Commerford PJ, Franks JJ, Kirsch RE. Fibrin and fibrinogen related antigen in patients with stable and unstable coronary artery disease. N Engl J Med.1987; 317:1361-1365.
• 16.   Tataru MC, Heinrich JR, Junker, Schulte H, Von Eckardstein A, Assmann G, et al. D- Dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction. European Heart Journal. 1999; 20:1493 1502.
• 17.   Ajay k Singh, Vikas Gupta, Neelma Singh, Sanjeev K. Singha, Nivedita Singh. Role of immunoturbic plasma fibrin D-dimer test in patients with coronary artery disease as well as ischemic heart disease in emergency medicine. Int J Cur Biomed Phar Res. 2011; 1(2):31-33.
• 18.   Wolfgang Koenig. Inflammation and coronary heart disease: An Overview. Cardiology in review. 2001; 9(1):31-35.
• 19.   Eleni S Nakou, Evangelos N Liberopoulos, Haralampos J Milionis, Moses S Elisaf. The role of reactive protein in atherosclerotic cardiovascular disease: An overview. Current Vascular Pharmacology. 2008; 6:258-270.
• 20.   Michael B Clearfield. C - reactive protein: A new risk assessment tool for cardiovascular disease. JAOA. 2005; 105(9):409-416.
• 21.   Shishir Kumar Basak, KM Akhtaruzzaman, Ashok Kumar Kundu, Sudhangshu Ranjan Dey, Md Faruque Uddin. Prognostic Value of High sensitivity C – reactive protein in Acute ST - segment elevation Myocardial Infarction in Hospitalized Patients. Medicine Today .2012; 24 (1):36-39.
• 22.   Eun Jin Choi, Min - Ho Shin, Won Yu Kang, Sun Ho Hwang, Wan Kim, Seung Wook Bak. Elevated hs-CRP in Patients with Stable Angina Pectoris. Available from: http://dx.doi.org/10.3904/ kjm.2012.82.1.45.
• 23.   Teresa Lozano, Javier Ena, VicentaAlmenar, Marisa Graells, Jaun Molina, Isabel Antorrena, et al. Evaluation of patients with acute chest pain of uncertain origin by means of serial measurement of high sensitivity C - reactive protein. Rev Esp Cardiol. 2007; 60 (8):817-24.
• 24.   Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Saia F, Taglieri N, et al. Predictive value of high sensitivity C - reactive protein in patients with ST - elevation myocardial infarction treated with percutaneous coronary intervention. European Heart Journal, 2008; 29:1241–1249. Available from: doi:10.1093/eurheartj/ehm338.
• 25.   Po - Cheng Chang, Ming - Jer Hsieh, Chun - Chi Chen, Cheng - Hung Lee, I - Chang Hsieh. Subclinical atherosclerotic plaques and significant coronary artery stenoses in Stable Angina patients present equivalent inflammatory activity. ActaCardiol Sin. 2008; 24:21-28.
• 26.   Minno Soinio, Jukka Marniemi, Markkukaakso, et al. High sensitive C - reactive protein and coronary heart disease mortality in patients with type 2-diabetes. Diabetes Care. 2006; 29(2).329-333.
• 27.   Reza Madadi, Katayoon Haddadian, Ebrahim Ghaderi, Kajal Karimi. Diagnostic value of high sensitivity C-reactive protein in differentiating unstable angina from myocardial infarction. Chronic Diseases Journal. 2013. 1(1):7-12.

Data Sharing Statement

Funding